David Scieszka

David Scieszka is the Founder and CEO of Vertical Longevity Pharmaceuticals, a biotechnology company focused on longevity science and therapeutics. In this role, he leads the company’s strategic vision, research direction, and business development efforts in the emerging longevity biotech space. He completed his PhD in biomedical sciences at The University of New Mexico School of Medicine (2019-2023), building a strong foundation in physiology, longevity medicine in real world settings, and biomedical research. His background bridges clinical training with entrepreneurial leadership in translational biotech, positioning him at the intersection of scientific research, drug development, and company building. David brings expertise in early-stage biotech company formation, longevity pharmaceuticals, research and development strategy, and the translation of biomedical science into therapeutic candidates.